{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:02:28Z","timestamp":1789826548462,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00436-022-07544-1","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T02:02:16Z","timestamp":1653530536000},"page":"2129-2140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection"],"prefix":"10.1007","volume":"121","author":[{"given":"Luciana M.","family":"Ribeiro Antinarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00edcolas","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V. C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S. V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria R. S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilson David","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ant\u00f4nio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Soares Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"7544_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","volume":"184","author":"JM Barichello","year":"1999","unstructured":"Barichello JM, Morishita M, Takayama K, Nagai T (1999) Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm 184:189\u2013198","journal-title":"Int J Pharm"},{"key":"7544_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392:951\u2013970","journal-title":"Lancet"},{"key":"7544_CR3","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.2147\/IJN.S140363","volume":"12","author":"N Bruni","year":"2017","unstructured":"Bruni N, Stella B, Giraudo L, Della Pepa C, Gastaldi D, Dosio F (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomedicine 12:5289\u20135311","journal-title":"Int J Nanomedicine"},{"key":"7544_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cbi.2018.08.003","volume":"293","author":"SL Calixto","year":"2018","unstructured":"Calixto SL, Glanzmann N, Xavier Silveira MM, da Trindade GJ, Gorza Scopel KK, Torres de Aguiar T, DaMatta RA, Macedo GC, da Silva AD, Coimbra ES (2018) Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp. Chem Biol Interact 293:141\u2013151","journal-title":"Chem Biol Interact"},{"key":"7544_CR5","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1128\/AAC.00520-11","volume":"55","author":"L Carvalho","year":"2011","unstructured":"Carvalho L, Luque-Ortega JR, L\u00f3pez-Mart\u00edn C, Castanys S, Rivas L, Gamarro F (2011) The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase. Antimicrob Agents Chemother 55:4204\u20134210","journal-title":"Antimicrob Agents Chemother"},{"key":"7544_CR6","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1128\/AAC.01787-15","volume":"60","author":"EF Cunha-J\u00fanior","year":"2016","unstructured":"Cunha-J\u00fanior EF, Martins TM, Canto-Cavalheiro MM, Marques PR, Portari EA, Coelho MG, Netto CD, Costa PR, Sabino KC, Torres-Santos EC (2016) Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis. Antimicrob Agents Chemother 60:3794\u20133801","journal-title":"Antimicrob Agents Chemother"},{"key":"7544_CR7","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67:2576\u20132597","journal-title":"J Antimicrob Chemother"},{"key":"7544_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","volume":"65","author":"MC Duarte","year":"2016","unstructured":"Duarte MC, Lage LM, Lage DP, Martins VT, Carvalho AM, Roatt BM, Menezes-Souza D, Tavares CA, Alves RJ, Barichello JM, Coelho EA (2016) Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Parasitol Int 65:728\u2013736","journal-title":"Parasitol Int"},{"key":"7544_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00436-020-06971-2","volume":"120","author":"CS Freitas","year":"2021","unstructured":"Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendon\u00e7a DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Ch\u00e1vez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, P\u00e1dua RM, Coelho EAF (2021) Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 120:321\u2013335","journal-title":"Parasitol Res"},{"key":"7544_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DDDT.S146521","volume":"12","author":"M Ghorbani","year":"2017","unstructured":"Ghorbani M, Farhoudi R (2017) Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther 12:25\u201340","journal-title":"Drug Des Devel Ther"},{"key":"7544_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pim.12100","volume":"36","author":"KJ Gollob","year":"2014","unstructured":"Gollob KJ, Viana AG, Dutra WO (2014) Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol 36:367\u2013376","journal-title":"Parasite Immunol"},{"key":"7544_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpddr.2020.08.002","volume":"14","author":"L Herrera","year":"2020","unstructured":"Herrera L, Llanes A, \u00c1lvarez J, Degracia K, Restrepo CM, Rivera R, Stephens DE, Dang HT, Larionov OV, Lleonart R, Fern\u00e1ndez PL (2020) Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection. Int J Parasitol Drugs Drug Resist 14:56\u201361","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7544_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00281-020-00788-y","volume":"42","author":"PM Kaye","year":"2020","unstructured":"Kaye PM, Cruz I, Picado A, Van Bocxlaer K, Croft SL (2020) Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs. Semin Immunopathol 42:247\u2013264","journal-title":"Semin Immunopathol"},{"key":"7544_CR14","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1007\/s00436-016-5181-4","volume":"115","author":"LM Lage","year":"2016","unstructured":"Lage LM, Barichello JM, Lage DP, Mendon\u00e7a DV, Carvalho AM, Rodrigues MR, Menezes-Souza D, Roatt BM, Alves RJ, Tavares CA, Coelho EA, Duarte MC (2016) An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis. Parasitol Res 115:4083\u20134095","journal-title":"Parasitol Res"},{"key":"7544_CR15","first-page":"193","volume":"10","author":"JAL Lindoso","year":"2018","unstructured":"Lindoso JAL, Moreira CHV, Cunha MA, Queiroz IT (2018) Visceral leishmaniasis and HIV coinfection: current perspectives. HIV AIDS (auckl) 10:193\u2013201","journal-title":"HIV AIDS (auckl)"},{"key":"7544_CR16","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.2147\/IJN.S122746","volume":"12","author":"Y Liu","year":"2017","unstructured":"Liu Y, Fu S, Lin L, Cao Y, Xie X, Yu H, Chen M, Li H (2017) Redox-sensitive Pluronic F127-tocopherol micelles: synthesis, characterization, and cytotoxicity evaluation. Int J Nanomedicine 12:2635\u20132644","journal-title":"Int J Nanomedicine"},{"key":"7544_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.exppara.2010.11.010","volume":"127","author":"G Malafaia","year":"2011","unstructured":"Malafaia G, Marcon Lde N, Pereira Lde F, Pedrosa ML, Rezende SA (2011) Leishmania chagasi: effect of the iron deficiency on the infection in BALB\/c mice. Exp Parasitol 127:719\u2013723","journal-title":"Exp Parasitol"},{"key":"7544_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejmech.2019.07.010","volume":"180","author":"JI Manzano","year":"2019","unstructured":"Manzano JI, Konstantinovi\u0107 J, Scaccabarozzi D, Perea A, Pavi\u0107 A, Cavicchini L, Basilico N, Gamarro F, \u0160olaja BA (2019) 4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania. Eur J Med Chem 180:28\u201340","journal-title":"Eur J Med Chem"},{"key":"7544_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.exppara.2016.07.005","volume":"169","author":"DV Mendon\u00e7a","year":"2016","unstructured":"Mendon\u00e7a DV, Lage LM, Lage DP, Ch\u00e1vez-Fumagalli MA, Ludolf F, Roatt BM, Menezes-Souza D, Faraco AA, Castilho RO, Tavares CA, Barichello JM, Duarte MC, Coelho EA (2016) Poloxamer 407 (Pluronic(\u00ae) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis. Exp Parasitol 169:34\u201342","journal-title":"Exp Parasitol"},{"key":"7544_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exppara.2018.02.003","volume":"186","author":"DVC Mendon\u00e7a","year":"2018","unstructured":"Mendon\u00e7a DVC, Martins VT, Lage DP, Dias DS, Ribeiro PAF, Carvalho AMRS, Dias ALT, Miyazaki CK, Menezes-Souza D, Roatt BM, Tavares CAP, Barichello JM, Duarte MC, Coelho EAF (2018) Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. Exp Parasitol 186:24\u201335","journal-title":"Exp Parasitol"},{"key":"7544_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","volume":"109","author":"DVC Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a DVC, Tavares GSV, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PAF, Ottoni FM, Antinarelli LMR, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Ch\u00e1vez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF (2019) In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic\u00ae F127-based polymeric micelle system against Leishmania amazonensis infection. Biomed Pharmacother 109:779\u2013787","journal-title":"Biomed Pharmacother"},{"key":"7544_CR22","doi-asserted-by":"publisher","first-page":"108205","DOI":"10.1016\/j.exppara.2021.108205","volume":"233","author":"DVC Mendon\u00e7a","year":"2022","unstructured":"Mendon\u00e7a DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Ch\u00e1vez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF (2022) Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. Exp Parasitol 233:108205","journal-title":"Exp Parasitol"},{"key":"7544_CR23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","volume":"60","author":"B Monge-Maillo","year":"2015","unstructured":"Monge-Maillo B, L\u00f3pez-V\u00e9lez R (2015) Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations. Clin Infect Dis 60:1398\u20131404","journal-title":"Clin Infect Dis"},{"key":"7544_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actatropica.2019.01.008","volume":"192","author":"J Oyama","year":"2019","unstructured":"Oyama J, Lera-Nonose DSSL, Ramos-Milar\u00e9 \u00c1CFH, Padilha Ferreira FB, de Freitas CF, Caetano W, Hioka N, Silveira TGV, Lonardoni MVC (2019) Potential of Pluronics\u00ae P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy. Acta Trop 192:11\u201321","journal-title":"Acta Trop"},{"key":"7544_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fcimb.2019.00229","volume":"9","author":"KM Rebello","year":"2019","unstructured":"Rebello KM, Andrade-Neto VV, Gomes CRB, de Souza MVN, Branquinha MH, Santos ALS, Torres-Santos EC, d\u2019Avila-Levy CM (2019) Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches. Front Cell Infect Microbiol 9:229","journal-title":"Front Cell Infect Microbiol"},{"key":"7544_CR26","doi-asserted-by":"publisher","first-page":"108059","DOI":"10.1016\/j.exppara.2020.108059","volume":"221","author":"TAR Reis","year":"2021","unstructured":"Reis TAR, Oliveira-da-Silva JA, Tavares GSV, Mendon\u00e7a DVC, Freitas CS, Costa RR, Lage DP, Martins VT, Machado AS, Ramos FF, Silva AM, Ludolf F, Antinarelli LMR, Brito RCF, Ch\u00e1vez-Fumagalli MA, Humbert MV, Roatt BM, Coimbra ES, Coelho EAF (2021) Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. Exp Parasitol 221:108059","journal-title":"Exp Parasitol"},{"key":"7544_CR27","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt BM, de Oliveira Cardoso JM, De Brito RCF, Coura-Vital W, de Oliveira Aguiar-Soares RD, Reis AB (2020) Recent advances and new strategies on leishmaniasis treatment. Appl Microbiol Biotechnol 104:8965\u20138977","journal-title":"Appl Microbiol Biotechnol"},{"key":"7544_CR28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms18061296","volume":"18","author":"BM Scorza","year":"2017","unstructured":"Scorza BM, Carvalho EM, Wilson ME (2017) Cutaneous Manifestations of Human and Murine Leishmaniasis. Int J Mol Sci 18:1296","journal-title":"Int J Mol Sci"},{"key":"7544_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1385\/IR:27:2-3:489","volume":"27","author":"P Scott","year":"2003","unstructured":"Scott P (2003) Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res 27:489\u2013498","journal-title":"Immunol Res"},{"key":"7544_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","volume":"105","author":"PK Singh","year":"2017","unstructured":"Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, Bora HK, Raval K, Meher JG, Gayen JR, Dube A, Chourasia MK (2017) Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol 105:1220\u20131231","journal-title":"Int J Biol Macromol"},{"key":"7544_CR31","first-page":"e00792","volume":"62","author":"AJ Sousa-Batista","year":"2018","unstructured":"Sousa-Batista AJ, Escrivani-Oliveira D, Falc\u00e3o CAB, Philipon CIMDS, Rossi-Bergmann B (2018) Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis. Antimicrob Agents Chemother 62:e00792-e818","journal-title":"Antimicrob Agents Chemother"},{"key":"7544_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Shankar P, Mishra J, Singh S (2016) Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors 9:277","journal-title":"Parasit Vectors"},{"key":"7544_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parint.2018.10.005","volume":"68","author":"GSV Tavares","year":"2019","unstructured":"Tavares GSV, Mendon\u00e7a DVC, Miyazaki CK, Lage DP, Soyer TG, Carvalho LM, Ottoni FM, Dias DS, Ribeiro PAF, Antinarelli LMR, Ludolf F, Duarte MC, Coimbra ES, Ch\u00e1vez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF (2019) A Pluronic\u00ae F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection. Parasitol Int 68:63\u201372","journal-title":"Parasitol Int"},{"key":"7544_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1051\/parasite\/2020027","volume":"27","author":"GSV Tavares","year":"2020","unstructured":"Tavares GSV, Mendon\u00e7a DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Ch\u00e1vez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF (2020) A clioquinol-containing Pluronic\u00ae F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model. Parasite 27:29","journal-title":"Parasite"},{"key":"7544_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijantimicag.2018.06.016","volume":"52","author":"E Valdivieso","year":"2018","unstructured":"Valdivieso E, Mej\u00edas F, Carrillo E, S\u00e1nchez C, Moreno J (2018) Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B. Int J Antimicrob Agents 52:682\u2013687","journal-title":"Int J Antimicrob Agents"},{"key":"7544_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.msec.2017.07.040","volume":"81","author":"JK Valenzuela-Oses","year":"2017","unstructured":"Valenzuela-Oses JK, Garc\u00eda MC, Feitosa VA, Pachioni-Vasconcelos JA, Gomes-Filho SM, Louren\u00e7o FR, Cerize NNP, Bass\u00e8res DS, Rangel-Yagui CO (2017) Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment. Mater Sci Eng C Mater Biol Appl 81:327\u2013333","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"7544_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijpddr.2020.04.004","volume":"13","author":"L Van Bockstal","year":"2020","unstructured":"Van Bockstal L, Bult\u00e9 D, Hendrickx S, Sadlova J, Volf P, Maes L, Caljon G (2020) Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection. Int J Parasitol Drugs Drug Resist 13:16\u201321","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7544_CR38","unstructured":"World Health Organization. 2020. Leishmaniasis, http:\/\/www.who.int\/topics\/leishmaniasis\/en\/, Accessed data: 2 December 2020"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07544-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:45:52Z","timestamp":1744202752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07544-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7544"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07544-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}